首页> 美国卫生研究院文献>RNA >Artificial mirtron-mediated gene knockdown: Functional DMPK silencing in mammalian cells
【2h】

Artificial mirtron-mediated gene knockdown: Functional DMPK silencing in mammalian cells

机译:人工mirtron介导的基因敲低:哺乳动物细胞中的功能性DMPK沉默。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mirtrons are introns that form pre-miRNA hairpins after splicing to produce RNA interference (RNAi) effectors distinct from Drosha-dependent intronic miRNAs. Here we present a design algorithm for artificial mirtrons and demonstrate, for the first time, efficient gene knockdown of myotonic dystrophy protein kinase (DMPK) target sequences in Renilla luciferase 3′ UTR and subsequently pathogenic DMPK mRNA, causative of Type I myotonic dystrophy, using artificial mirtrons cloned as eGFP introns. Deep sequencing of artificial mirtrons suggests that functional mature transcripts corresponding to the designed sequence were produced in high abundance. They were further shown to be splicing-dependent, Drosha-independent, and partially dependent on exportin-5, resulting in the precise generation of pre-miRNAs. In a murine myoblast line containing a pathogenic copy of human DMPK with more than 500 CUG repeats, the DMPK artificial mirtron corrected DM1-associated splicing abnormalities of the Serca-1 mRNA, demonstrating the therapeutic potential of mirtron-mediated RNAi. Thus, further development and exploitation of the unique properties of mirtrons will benefit future research and therapeutic RNAi applications as an alternative to conventional RNAi strategies.
机译:Mirtrons是内含子,在剪接产生不同于Drosha依赖性内含子miRNA的RNA干扰(RNAi)效应子后形成pre-miRNA发夹。在这里,我们提出了一种用于人工mirtrons的设计算法,并首次证明了使用雷尼利亚萤光素酶3'UTR的强直性肌营养不良蛋白激酶(DMPK)靶序列和随后的致病性DMPK mRNA的有效基因敲低,这是引起I型强直性肌营养不良的原因人工反光子克隆为eGFP内含子。人工mirtrons的深度测序表明,与设计的序列相对应的功能性成熟转录本的产量很高。它们还被证明是剪接依赖性的,Drosha依赖性的,并且部分依赖于exportin-5,从而精确生成pre-miRNA。在含有致病性拷贝的人DMPK且有500个CUG重复的鼠成肌细胞系中,DMPK人工mirtron纠正了Serca-1 mRNA与DM1相关的剪接异常,证明了mirtron介导的RNAi的治疗潜力。因此,进一步开发和利用mirtrons的独特特性将有益于未来的研究和治疗性RNAi应用,作为常规RNAi策略的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号